| Summarizes grant income |
| | | | | | | | | | | | | | | For the Three Months Ended | | For the Six Months Ended | | | June 30, | | June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | Grant income: | | | | | | | | | | | | | CPRIT AML Grant1 | | $ | 256,890 | | $ | 319,610 | | $ | 465,399 | | $ | 537,254 | FDA Grant | | | 20,055 | | | 104,461 | | | 22,958 | | | 104,461 | SBIR AML Grant | | | — | | | 11,594 | | | 116,504 | | | 108,317 | Decoy Grant | | | 167,206 | | | 189,076 | | | 265,840 | | | 203,291 | PANACEA Grant | | | 105,601 | | | 53,168 | | | 179,079 | | | 61,147 | CPRIT Pancreatic Grant1 | | | 131,827 | | | 183,275 | | | 383,490 | | | 195,818 | Total grant income | | $ | 681,579 | | $ | 861,184 | | $ | 1,433,270 | | $ | 1,210,288 |
(1) Both CPRIT grants are subject to certain revenue-sharing arrangements, as per the grant agreements (see Note 11).
|